I think you miss my point.
For Bisantrene to be fully exploited to assist cancer sufferers, I assume Race maintains control of the molecule and therefore licenses it out for BPs for their field of excellence in Cancer. That way Race can continue to develop Bisantrene in combination with whatever they please to assist other patients. i.e. instead of a one time large lump of money we are likely to get a smaller lump of money and ongoing revenue from licensing. Either way, I expect it to be a game changer for all holders and the second option would likely have a higher value for holders. Of course you can still sell your shares at anytime.
...and once set up, Dr T does not need to continue his involvement in Race. They could arguably place molecule development to a company like Vertex if they so wanted, and maybe another innovative Aussie coy or just keep it inhouse.
Cheers
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC
race oncology ltd
Add to My Watchlist
0.41%
!
$1.23

RAC - Charts & Price Action, page-25452
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $212.8M |
Open | High | Low | Value | Volume |
$1.24 | $1.26 | $1.22 | $65.77K | 52.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4560 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 16594 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4560 | 1.225 |
2 | 6212 | 1.220 |
3 | 7276 | 1.210 |
1 | 600 | 1.205 |
5 | 26407 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.245 | 16594 | 4 |
1.250 | 432 | 1 |
1.260 | 10432 | 2 |
1.270 | 637 | 1 |
1.280 | 4060 | 1 |
Last trade - 14.00pm 25/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |